www.aobiome.com Open in urlscan Pro
2606:4700:20::681a:c12  Public Scan

Form analysis
0 forms found in the DOM

Text Content

Skip to content

AOBiome

 * Our Science
   * AOB and it’s impact on Inflammatory Conditions, and related Systemic
     Effects
   * Published Articles and Papers
 * Pipeline
 * Press
   * Company News
   * Press Releases
   * Conferences and Events
 * About Us
   * Leadership
   * Board
   * Investors
   * Contact Us




LIVE TOPICAL BIOTHERAPEUTICS FOR THE TREATMENT OF INFLAMMATORY SKIN DISORDERS

Learn More
•


LIVE TOPICAL BIOTHERAPEUTICS FOR THE TREATMENT OF INFLAMMATORY SKIN DISORDERS

Learn More


AN EVOLUTIONARY APPROACH TO RESTORING HEALTH

AOBiome Therapeutics is a late stage therapeutics company addressing a broad
range of inflammatory skin conditions by harnessing a single strain of class
defining Ammonia Oxidizing Bacteria (AOB), whose presence on the skin has been
eliminated through modern living.


RESTORING IMMUNE FUNCTIONALITY

Ammonia Oxidizing Bacteria may serve to restore proper immune response through
the down regulation of IL-4, IL-5, IL-13 and IL-31. Such markers are associated
with inappropriate inflammatory response in several diseases including the
pruritus (itch) pathway.


AOBIOME CURRENTLY HAS MULTIPLE
PHASE 2 CLINICAL PROGRAMS

AOBIOME CURRENTLY HAS PHASE 2 CLINICAL PROGRAMS IN ACNE, ECZEMA AND ROSACEA.

 

Learn More




COMMITTED TO TRANSFORMING & IMPROVING HUMAN HEALTH

We believe that the restoration of the symbiotic relationship between bacteria
and humans
will have a profound impact on human health.

Clinical Trials





Science





Manufacturing





Pipeline







 


Clinical Trials
Science
Manufacturing
About

In the News
May 10, 2022 · Cambridge, MA
AOBiome’s CEO & President Todd Krueger featured in CEO/CFO Magazine
Read More
February 22, 2022 · Cambridge, MA
AOBiome’s B244 demonstrated positive results from its Phase 2b trial for both
Pruritus (Itch) and Appearance of Atopic Dermatitis (Eczema)
Read More
November 16, 2021 · Cambridge, MA
AOBiome Achieves Landmark Recruitment Goal in Largest Clinical Trial Ever
Powered by a Live Topical Biotherapeutic
Read More


Read More



 * Our Science
   * AOB and it’s impact on Inflammatory Conditions, and related Systemic
     Effects
   * Published Articles and Papers
 * Pipeline
 * Press
   * Company News
   * Press Releases
   * Conferences and Events
 * About Us
   * Leadership
   * Board
   * Investors
   * Contact Us

© 2019 AOBiome | Terms & Conditions | Site Credits